{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:11:29Z","timestamp":1794852689955,"version":"4.9.1"},"reference-count":304,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1R01AR073004-01A1"],"award-info":[{"award-number":["1R01AR073004-01A1"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR071189-01A1"],"award-info":[{"award-number":["R01AR071189-01A1"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX004293-01A1"],"award-info":[{"award-number":["1I01BX004293-01A1"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["NIH Z01-ES-101585"],"award-info":[{"award-number":["NIH Z01-ES-101585"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41435-020-0096-6","type":"journal-article","created":{"date-parts":[[2020,3,22]],"date-time":"2020-03-22T20:02:57Z","timestamp":1584907377000},"page":"150-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders"],"prefix":"10.1038","volume":"21","author":[{"given":"Radomir M.","family":"Slominski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Tuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulak R.","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-4445","authenticated-orcid":false,"given":"Anton M.","family":"Jetten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Postlethwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chander","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8963-3995","authenticated-orcid":false,"given":"Andrzej T.","family":"Slominski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"96_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32:81\u2013151.","journal-title":"Endocr Rev"},{"key":"96_CR2","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1074\/jbc.M112.417873","volume":"288","author":"PR Manna","year":"2013","unstructured":"Manna PR, Cohen-Tannoudji J, Counis R, Garner CW, Huhtaniemi I, Kraemer FB, et al. Mechanisms of action of hormone-sensitive lipase in mouse Leydig cells: its role in the regulation of the steroidogenic acute regulatory protein. J Biol Chem. 2013;288:8505\u201318.","journal-title":"J Biol Chem"},{"key":"96_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12020-015-0715-6","volume":"51","author":"PR Manna","year":"2016","unstructured":"Manna PR, Stetson CL, Slominski AT, Pruitt K. Role of the steroidogenic acute regulatory protein in health and disease. Endocrine. 2016;51:7\u201321.","journal-title":"Endocrine"},{"key":"96_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1568008053174714","volume":"5","author":"PR Manna","year":"2005","unstructured":"Manna PR, Stocco DM. Regulation of the steroidogenic acute regulatory protein expression: functional and physiological consequences. Curr Drug Targets Immune Endocr Metab Disord. 2005;5:93\u2013108.","journal-title":"Curr Drug Targets Immune Endocr Metab Disord"},{"key":"96_CR5","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1210\/me.2004-0532","volume":"19","author":"DM Stocco","year":"2005","unstructured":"Stocco DM, Wang X, Jo Y, Manna PR. Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. Mol Endocrinol. 2005;19:2647\u201359.","journal-title":"Mol Endocrinol"},{"key":"96_CR6","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1194\/jlr.R016675","volume":"52","author":"WL Miller","year":"2011","unstructured":"Miller WL, Bose HS. Early steps in steroidogenesis: intracellular cholesterol trafficking. J Lipid Res. 2011;52:2111\u201335.","journal-title":"J Lipid Res"},{"key":"96_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2014.12.011","volume":"408","author":"AF Castillo","year":"2015","unstructured":"Castillo AF, Orlando U, Helfenberger KE, Poderoso C, Podesta EJ. The role of mitochondrial fusion and StAR phosphorylation in the regulation of StAR activity and steroidogenesis. Mol Cell Endocrinol. 2015;408:73\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR8","doi-asserted-by":"crossref","unstructured":"Manna PR, Ahmed AU, Yang S, Narasimhan M, Cohen-Tannoudji J, Slominski AT, et al. Genomic profiling of the steroidogenic acute regulatory protein in breast cancer: in silico assessments and a mechanistic perspective. Cancers (Basel). 2019;11:623.","DOI":"10.3390\/cancers11050623"},{"key":"96_CR9","doi-asserted-by":"crossref","first-page":"28314","DOI":"10.1016\/S0021-9258(18)46930-X","volume":"269","author":"BJ Clark","year":"1994","unstructured":"Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 1994;269:28314\u201322.","journal-title":"J Biol Chem"},{"key":"96_CR10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/me.2006-0303","volume":"21","author":"WL Miller","year":"2007","unstructured":"Miller WL. StAR search\u2013what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol Endocrinol. 2007;21:589\u2013601.","journal-title":"Mol Endocrinol"},{"key":"96_CR11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/molehr\/gap025","volume":"15","author":"PR Manna","year":"2009","unstructured":"Manna PR, Dyson MT, Stocco DM. Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives. Mol Hum Reprod. 2009;15:321\u201333.","journal-title":"Mol Hum Reprod"},{"key":"96_CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2013.04.014","volume":"379","author":"WL Miller","year":"2013","unstructured":"Miller WL. Steroid hormone synthesis in mitochondria. Mol Cell Endocrinol. 2013;379:62\u201373.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/edrv.23.2.0462","volume":"23","author":"M Ascoli","year":"2002","unstructured":"Ascoli M, Fanelli F, Segaloff DL. The lutropin\/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002;23:141\u201374.","journal-title":"Endocr Rev"},{"key":"96_CR14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/hmg\/11.3.301","volume":"11","author":"PR Manna","year":"2002","unstructured":"Manna PR, Joshi L, Reinhold VN, Aubert ML, Suganuma N, Pettersson K, et al. Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone. Hum Mol Genet. 2002;11:301\u201315.","journal-title":"Hum Mol Genet"},{"key":"96_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-0378(02)00020-7","volume":"57","author":"DB Hales","year":"2002","unstructured":"Hales DB. Testicular macrophage modulation of Leydig cell steroidogenesis. J Reprod Immunol. 2002;57:3\u201318.","journal-title":"J Reprod Immunol"},{"key":"96_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1677\/jme.1.02065","volume":"37","author":"PR Manna","year":"2006","unstructured":"Manna PR, Chandrala SP, Jo Y, Stocco DM. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation. J Mol Endocrinol. 2006;37:81\u201395.","journal-title":"J Mol Endocrinol"},{"key":"96_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/en.2008-0368","volume":"150","author":"PR Manna","year":"2009","unstructured":"Manna PR, Dyson MT, Jo Y, Stocco DM. Role of dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene 1 in protein kinase A- and protein kinase C-mediated regulation of the steroidogenic acute regulatory protein expression in mouse Leydig tumor cells: mechanism of action. Endocrinology. 2009;150:187\u201399.","journal-title":"Endocrinology"},{"key":"96_CR18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2018.12.145","volume":"509","author":"PR Manna","year":"2019","unstructured":"Manna PR, Ahmed AU, Vartak D, Molehin D, Pruitt K. Overexpression of the steroidogenic acute regulatory protein in breast cancer: Regulation by histone deacetylase inhibition. Biochem Biophys Res Commun. 2019;509:476\u201382.","journal-title":"Biochem Biophys Res Commun"},{"key":"96_CR19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mad.2015.08.007","volume":"150","author":"PR Manna","year":"2015","unstructured":"Manna PR, Stetson CL, Daugherty C, Shimizu I, Syapin PJ, Garrel G, et al. Up-regulation of steroid biosynthesis by retinoid signaling: Implications for aging. Mech Ageing Dev. 2015;150:74\u201382.","journal-title":"Mech Ageing Dev"},{"key":"96_CR20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/JME-07-0065","volume":"39","author":"PR Manna","year":"2007","unstructured":"Manna PR, Stocco DM. Crosstalk of CREB and Fos\/Jun on a single cis-element: transcriptional repression of the steroidogenic acute regulatory protein gene. J Mol Endocrinol. 2007;39:261\u201377.","journal-title":"J Mol Endocrinol"},{"key":"96_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2008.12.009","volume":"302","author":"PR Manna","year":"2009","unstructured":"Manna PR, Dyson MT, Stocco DM. Role of basic leucine zipper proteins in transcriptional regulation of the steroidogenic acute regulatory protein gene. Mol Cell Endocrinol. 2009;302:1\u201311.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3181\/0903-MR-97","volume":"234","author":"HA Lavoie","year":"2009","unstructured":"Lavoie HA, King SR. Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B. Exp Biol Med (Maywood). 2009;234:880\u2013907.","journal-title":"Exp Biol Med (Maywood)"},{"key":"96_CR23","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199612193352503","volume":"335","author":"HS Bose","year":"1996","unstructured":"Bose HS, Sugawara T, Strauss JF,3rd, Miller WL. International Congenital Lipoid Adrenal Hyperplasia Consortium The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N. Engl J Med. 1996;335:1870\u20138.","journal-title":"N. Engl J Med"},{"key":"96_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsbmb.2009.10.005","volume":"118","author":"WR Miller","year":"2010","unstructured":"Miller WR. Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer. J Steroid Biochem Mol Biol. 2010;118:273\u20136.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"96_CR25","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1073\/pnas.94.16.8462","volume":"94","author":"H Watari","year":"1997","unstructured":"Watari H, Arakane F, Moog-Lutz C, Kallen CB, Tomasetto C, Gerton GL, et al. MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc Natl Acad Sci USA. 1997;94:8462\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"96_CR26","doi-asserted-by":"crossref","first-page":"33300","DOI":"10.1074\/jbc.M200003200","volume":"277","author":"M Zhang","year":"2002","unstructured":"Zhang M, Liu P, Dwyer NK, Christenson LK, Fujimoto T, Martinez F, et al. MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J Biol Chem. 2002;277:33300\u201310.","journal-title":"J Biol Chem"},{"key":"96_CR27","doi-asserted-by":"crossref","first-page":"22183","DOI":"10.1074\/jbc.R300003200","volume":"278","author":"RE Soccio","year":"2003","unstructured":"Soccio RE, Breslow JL. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J Biol Chem. 2003;278:22183\u20136.","journal-title":"J Biol Chem"},{"key":"96_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0303-7207(03)00063-7","volume":"202","author":"JF Strauss 3rd","year":"2003","unstructured":"Strauss JF 3rd, Kishida T, Christenson LK, Fujimoto T, Hiroi H. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol Cell Endocrinol. 2003;202:59\u201365.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR29","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1210\/en.2003-1034","volume":"145","author":"RC Tuckey","year":"2004","unstructured":"Tuckey RC, Bose HS, Czerwionka I, Miller WL. Molten globule structure and steroidogenic activity of N-218 MLN64 in human placental mitochondria. Endocrinology. 2004;145:1700\u20137.","journal-title":"Endocrinology"},{"key":"96_CR30","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1194\/jlr.E008854","volume":"51","author":"A Rigotti","year":"2010","unstructured":"Rigotti A, Cohen DE, Zanlungo S. STARTing to understand MLN64 function in cholesterol transport. J Lipid Res. 2010;51:2015\u20137.","journal-title":"J Lipid Res"},{"key":"96_CR31","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.86.24.9813","volume":"86","author":"AG Mukhin","year":"1989","unstructured":"Mukhin AG, Papadopoulos V, Costa E, Krueger KE. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci USA. 1989;86:9813\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"96_CR32","doi-asserted-by":"crossref","first-page":"15015","DOI":"10.1016\/S0021-9258(18)77217-7","volume":"265","author":"KE Krueger","year":"1990","unstructured":"Krueger KE, Papadopoulos V. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J Biol Chem. 1990;265:15015\u201322.","journal-title":"J Biol Chem"},{"key":"96_CR33","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1016\/S0021-9258(19)39661-9","volume":"265","author":"V Papadopoulos","year":"1990","unstructured":"Papadopoulos V, Mukhin AG, Costa E, Krueger KE. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem. 1990;265:3772\u20139.","journal-title":"J Biol Chem"},{"key":"96_CR34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0039-128X(96)00154-7","volume":"62","author":"V Papadopoulos","year":"1997","unstructured":"Papadopoulos V, Amri H, Boujrad N, Cascio C, Culty M, Garnier M, et al. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids. 1997;62:21\u20138.","journal-title":"Steroids"},{"key":"96_CR35","doi-asserted-by":"crossref","first-page":"32129","DOI":"10.1074\/jbc.272.51.32129","volume":"272","author":"V Papadopoulos","year":"1997","unstructured":"Papadopoulos V, Amri H, Li H, Boujrad N, Vidic B, Garnier M. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J Biol Chem. 1997;272:32129\u201335.","journal-title":"J Biol Chem"},{"key":"96_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2010.06.013","volume":"327","author":"A Batarseh","year":"2010","unstructured":"Batarseh A, Papadopoulos V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol. 2010;327:1\u201312.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR37","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.biocel.2013.03.004","volume":"45","author":"CJ Austin","year":"2013","unstructured":"Austin CJ, Kahlert J, Kassiou M, Rendina LM. The translocator protein (TSPO): a novel target for cancer chemotherapy. Int J Biochem Cell Biol. 2013;45:1212\u20136.","journal-title":"Int J Biochem Cell Biol"},{"key":"96_CR38","first-page":"3205","volume":"8","author":"K Maaser","year":"2002","unstructured":"Maaser K, Grabowski P, Sutter AP, Hopfner M, Foss HD, Stein H, et al. Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer. Clin Cancer Res. 2002;8:3205\u20139.","journal-title":"Clin Cancer Res"},{"key":"96_CR39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1053\/rmed.2001.1162","volume":"97","author":"Z Han","year":"2003","unstructured":"Han Z, Junxu, Zhong N. Expression of matrix metalloproteinases MMP-9 within the airways in asthma. Respir Med. 2003;97:563\u20137.","journal-title":"Respir Med"},{"key":"96_CR40","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1158\/1078-0432.CCR-03-0988","volume":"10","author":"S Galiegue","year":"2004","unstructured":"Galiegue S, Casellas P, Kramar A, Tinel N, Simony-Lafontaine J. Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival. Clin Cancer Res. 2004;10:2058\u201364.","journal-title":"Clin Cancer Res"},{"key":"96_CR41","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6452","volume":"5","author":"RB Banati","year":"2014","unstructured":"Banati RB, Middleton RJ, Chan R, Hatty CR, Kam WW, Quin C, et al. Positron emission tomography and functional characterization of a complete PBR\/TSPO knockout. Nat Commun. 2014;5:5452.","journal-title":"Nat Commun"},{"key":"96_CR42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.placenta.2004.06.012","volume":"26","author":"RC Tuckey","year":"2005","unstructured":"Tuckey RC. Progesterone synthesis by the human placenta. Placenta. 2005;26:273\u201381.","journal-title":"Placenta"},{"key":"96_CR43","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1111\/j.1432-1033.2004.04356.x","volume":"271","author":"A Slominski","year":"2004","unstructured":"Slominski A, Zjawiony J, Wortsman J, Semak I, Stewart J, Pisarchik A, et al. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem. 2004;271:4178\u201388.","journal-title":"Eur J Biochem"},{"key":"96_CR44","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.chembiol.2005.06.010","volume":"12","author":"A Slominski","year":"2005","unstructured":"Slominski A, Semak I, Zjawiony J, Wortsman J, Gandy MN, Li J, et al. Enzymatic metabolism of ergosterol by cytochrome p450scc to biologically active 17alpha,24-dihydroxyergosterol. Chem Biol. 2005;12:931\u20139.","journal-title":"Chem Biol"},{"key":"96_CR45","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1111\/j.1742-4658.2005.04819.x","volume":"272","author":"A Slominski","year":"2005","unstructured":"Slominski A, Semak I, Zjawiony J, Wortsman J, Li W, Szczesniewski A, et al. The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J. 2005;272:4080\u201390.","journal-title":"FEBS J"},{"key":"96_CR46","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1111\/j.1742-4658.2006.05302.x","volume":"273","author":"A Slominski","year":"2006","unstructured":"Slominski A, Semak I, Wortsman J, Zjawiony J, Li W, Zbytek B, et al. An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J. 2006;273:2891\u2013901.","journal-title":"FEBS J"},{"key":"96_CR47","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.biocel.2012.07.027","volume":"44","author":"AT Slominski","year":"2012","unstructured":"Slominski AT, Kim TK, Chen J, Nguyen MN, Li W, Yates CR, et al. Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes. Int J Biochem Cell Biol. 2012;44:2003\u201318.","journal-title":"Int J Biochem Cell Biol"},{"key":"96_CR48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biocel.2014.08.004","volume":"55","author":"RC Tuckey","year":"2014","unstructured":"Tuckey RC, Slominski AT, Cheng CY, Chen J, Kim TK, Xiao M, et al. Lumisterol is metabolized by CYP11A1: discovery of a new pathway. Int J Biochem Cell Biol. 2014;55:24\u201334.","journal-title":"Int J Biochem Cell Biol"},{"key":"96_CR49","doi-asserted-by":"crossref","DOI":"10.1038\/srep14875","volume":"5","author":"AT Slominski","year":"2015","unstructured":"Slominski AT, Kim TK, Li W, Postlethwaite A, Tieu EW, Tang EKY, et al. Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. Sci Rep. 2015;5:14875.","journal-title":"Sci Rep"},{"issue":"Pt 3","key":"96_CR50","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/bj3080901","volume":"308","author":"P Lee-Robichaud","year":"1995","unstructured":"Lee-Robichaud P, Wright JN, Akhtar ME, Akhtar M. Modulation of the activity of human 17 alpha-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications. Biochem J. 1995;308(Pt 3):901\u20138.","journal-title":"Biochem J"},{"key":"96_CR51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-4731(89)90296-3","volume":"33","author":"JL Thomas","year":"1989","unstructured":"Thomas JL, Myers RP, Strickler RC. Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5\u20134-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes. J Steroid Biochem. 1989;33:209\u201317.","journal-title":"J Steroid Biochem"},{"key":"96_CR52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41435-019-0058-z","volume":"20","author":"TS Phan","year":"2019","unstructured":"Phan TS, Merk VM, Brunner T. Extra-adrenal glucocorticoid synthesis at epithelial barriers. Genes Immun. 2019;20:627\u2013640.","journal-title":"Genes Immun"},{"key":"96_CR53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1134\/S0006297913030103","volume":"78","author":"TA Sushko","year":"2013","unstructured":"Sushko TA, Gilep AA, Yantsevich AV, Usanov SA. Role of microsomal steroid hydroxylases in Delta7-steroid biosynthesis. Biochem (Mosc). 2013;78:282\u20139.","journal-title":"Biochem (Mosc)"},{"key":"96_CR54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004309","volume":"4","author":"AT Slominski","year":"2009","unstructured":"Slominski AT, Zmijewski MA, Semak I, Sweatman T, Janjetovic Z, Li W, et al. Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin. PloS ONE. 2009;4:e4309.","journal-title":"PloS ONE"},{"key":"96_CR55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0039-128X(02)00113-7","volume":"68","author":"LW Guo","year":"2003","unstructured":"Guo LW, Wilson WK, Pang J, Shackleton CH. Chemical synthesis of 7- and 8-dehydro derivatives of pregnane-3,17alpha,20-triols, potential steroid metabolites in Smith-Lemli-Opitz syndrome. Steroids. 2003;68:31\u201342.","journal-title":"Steroids"},{"key":"96_CR56","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1210\/jcem.84.3.5660","volume":"84","author":"CH Shackleton","year":"1999","unstructured":"Shackleton CH, Roitman E, Kratz LE, Kelley RI. Equine type estrogens produced by a pregnant woman carrying a Smith-Lemli-Opitz syndrome fetus. J Clin Endocrinol Metab. 1999;84:1157\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0039-128X(99)00022-7","volume":"64","author":"CH Shackleton","year":"1999","unstructured":"Shackleton CH, Roitman E, Kelley R. Neonatal urinary steroids in Smith-Lemli-Opitz syndrome associated with 7-dehydrocholesterol reductase deficiency. Steroids. 1999;64:481\u201390.","journal-title":"Steroids"},{"key":"96_CR58","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0039-128X(99)00026-4","volume":"64","author":"CH Shackleton","year":"1999","unstructured":"Shackleton CH, Roitman E, Kratz LE, Kelley RI. Midgestational maternal urine steroid markers of fetal Smith-Lemli-Opitz (SLO) syndrome (7-dehydrocholesterol 7-reductase deficiency). Steroids. 1999;64:446\u201352.","journal-title":"Steroids"},{"key":"96_CR59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2005.12.002","volume":"248","author":"MC Holmes","year":"2006","unstructured":"Holmes MC, Seckl JR. The role of 11beta-hydroxysteroid dehydrogenases in the brain. Mol Cell Endocrinol. 2006;248:9\u201314.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR60","first-page":"135","volume":"18","author":"PC White","year":"1997","unstructured":"White PC, Mune T, Agarwal AK. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev. 1997;18:135\u201356.","journal-title":"Endocr Rev"},{"key":"96_CR61","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nrendo.2009.106","volume":"5","author":"GP Chrousos","year":"2009","unstructured":"Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5:374\u201381.","journal-title":"Nat Rev Endocrinol"},{"key":"96_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1999.79.1.1","volume":"79","author":"AV Turnbull","year":"1999","unstructured":"Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev. 1999;79:1\u201371.","journal-title":"Physiol Rev"},{"key":"96_CR63","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","volume":"213","author":"W Vale","year":"1981","unstructured":"Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981;213:1394\u20137.","journal-title":"Science"},{"key":"96_CR64","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1152\/physrev.2000.80.3.979","volume":"80","author":"A Slominski","year":"2000","unstructured":"Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80:979\u20131020.","journal-title":"Physiol Rev"},{"key":"96_CR65","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2010.11.041","volume":"660","author":"LF Chan","year":"2011","unstructured":"Chan LF, Metherell LA, Clark AJ. Effects of melanocortins on adrenal gland physiology. Eur J Pharm. 2011;660:171\u201380.","journal-title":"Eur J Pharm"},{"key":"96_CR66","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1210\/edrv.19.6.0351","volume":"19","author":"AJ Clark","year":"1998","unstructured":"Clark AJ, Weber A. Adrenocorticotropin insensitivity syndromes. Endocr Rev. 1998;19:828\u201343.","journal-title":"Endocr Rev"},{"key":"96_CR67","first-page":"E489","volume":"247","author":"M Keller-Wood","year":"1984","unstructured":"Keller-Wood M, Shinsako J, Dallman MF. Interaction between stimulus intensity and corticosteroid feedback in control of ACTH. Am J Physiol. 1984;247:E489\u201394.","journal-title":"Am J Physiol"},{"key":"96_CR68","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","volume":"53","author":"C Tsigos","year":"2002","unstructured":"Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53:865\u201371.","journal-title":"J Psychosom Res"},{"key":"96_CR69","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1095\/biolreprod53.6.1417","volume":"53","author":"RE Nappi","year":"1995","unstructured":"Nappi RE, Rivest S. Stress-induced genetic expression of a selective corticotropin-releasing factor-receptor subtype within the rat ovaries: an effect dependent on the ovulatory cycle. Biol Reprod. 1995;53:1417\u201328.","journal-title":"Biol Reprod"},{"key":"96_CR70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(96)00178-6","volume":"72","author":"K Karalis","year":"1997","unstructured":"Karalis K, Muglia LJ, Bae D, Hilderbrand H, Majzoub JA. CRH and the immune system. J Neuroimmunol. 1997;72:131\u20136.","journal-title":"J Neuroimmunol"},{"key":"96_CR71","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/er.2012-1092","volume":"34","author":"AT Slominski","year":"2013","unstructured":"Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, Theoharides TC, Rivier J. Key role of CRF in the skin stress response system. Endocr Rev. 2013;34:827\u201384.","journal-title":"Endocr Rev"},{"key":"96_CR72","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2741\/2083","volume":"12","author":"S Kalantaridou","year":"2007","unstructured":"Kalantaridou S, Makrigiannakis A, Zoumakis E, Chrousos GP. Peripheral corticotropin-releasing hormone is produced in the immune and reproductive systems: actions, potential roles and clinical implications. Front Biosci. 2007;12:572\u201380.","journal-title":"Front Biosci"},{"key":"96_CR73","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0016-5085(94)90743-9","volume":"106","author":"Y Kawahito","year":"1994","unstructured":"Kawahito Y, Sano H, Kawata M, Yuri K, Mukai S, Yamamura Y, et al. Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon. Gastroenterology. 1994;106:859\u201365.","journal-title":"Gastroenterology"},{"key":"96_CR74","doi-asserted-by":"crossref","first-page":"8503","DOI":"10.1073\/pnas.0402693101","volume":"101","author":"PM Anton","year":"2004","unstructured":"Anton PM, Gay J, Mykoniatis A, Pan A, O\u2019Brien M, Brown D, et al. Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc Natl Acad Sci USA. 2004;101:8503\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"96_CR75","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.jid.5700607","volume":"127","author":"B Zbytek","year":"2007","unstructured":"Zbytek B, Slominski AT. CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes. J Invest Dermatol. 2007;127:730\u20132.","journal-title":"J Invest Dermatol"},{"key":"96_CR76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1925600","volume":"254","author":"K Karalis","year":"1991","unstructured":"Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 1991;254:421\u20133.","journal-title":"Science"},{"key":"96_CR77","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2005.01.014","volume":"162","author":"A Slominski","year":"2005","unstructured":"Slominski A, Zbytek B, Semak I, Sweatman T, Wortsman J. CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol. 2005;162:97\u2013102.","journal-title":"J Neuroimmunol"},{"key":"96_CR78","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1152\/ajpendo.00519.2004","volume":"288","author":"A Slominski","year":"2005","unstructured":"Slominski A, Zbytek B, Szczesniewski A, Semak I, Kaminski J, Sweatman T, et al. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab. 2005;288:E701\u20136.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"96_CR79","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.2741\/1966","volume":"11","author":"A Slominski","year":"2006","unstructured":"Slominski A, Zbytek B, Zmijewski M, Slominski RM, Kauser S, Wortsman J, et al. Corticotropin releasing hormone and the skin. Front Biosci. 2006;11:2230\u201348.","journal-title":"Front Biosci"},{"key":"96_CR80","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1016\/j.peptides.2006.07.017","volume":"27","author":"B Zbytek","year":"2006","unstructured":"Zbytek B, Pfeffer LM, Slominski AT. CRH inhibits NF-kappa B signaling in human melanocytes. Peptides. 2006;27:3276\u201383.","journal-title":"Peptides"},{"key":"96_CR81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/1874467210666170110125747","volume":"10","author":"DK Grammatopoulos","year":"2017","unstructured":"Grammatopoulos DK, Ourailidou S. CRH receptor signalling: potential roles in pathophysiology. Curr Mol Pharm. 2017;10:296\u2013310.","journal-title":"Curr Mol Pharm"},{"key":"96_CR82","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/er.2005-0034","volume":"27","author":"EW Hillhouse","year":"2006","unstructured":"Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev. 2006;27:260\u201386.","journal-title":"Endocr Rev"},{"key":"96_CR83","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1096\/fj.00-0850rev","volume":"15","author":"A Slominski","year":"2001","unstructured":"Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE, et al. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J. 2001;15:1678\u201393.","journal-title":"FASEB J"},{"key":"96_CR84","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00011-011-0329-2","volume":"60","author":"H Zhu","year":"2011","unstructured":"Zhu H, Wang J, Li J, Li S. Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery? Inflamm Res. 2011;60:715\u201321.","journal-title":"Inflamm Res"},{"key":"96_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18388\/abp.2010_2366","volume":"57","author":"MA Zmijewski","year":"2010","unstructured":"Zmijewski MA, Slominski AT. Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol. 2010;57:1\u201313.","journal-title":"Acta Biochim Pol"},{"key":"96_CR86","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1096\/fj.01-0487fje","volume":"15","author":"A Pisarchik","year":"2001","unstructured":"Pisarchik A, Slominski AT. Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J. 2001;15:2754\u20136.","journal-title":"FASEB J"},{"key":"96_CR87","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1043-2760(02)00670-7","volume":"13","author":"DK Grammatopoulos","year":"2002","unstructured":"Grammatopoulos DK, Chrousos GP. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab. 2002;13:436\u201344.","journal-title":"Trends Endocrinol Metab"},{"key":"96_CR88","first-page":"815","volume":"85","author":"A Slominski","year":"2000","unstructured":"Slominski A, Roloff B, Curry J, Dahiya M, Szczesniewski A, Wortsman J. The skin produces urocortin. J Clin Endocrinol Metab. 2000;85:815\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1615\/CritRevNeurobiol.v11.i1.30","volume":"11","author":"MG Castro","year":"1997","unstructured":"Castro MG, Morrison E. Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit Rev Neurobiol. 1997;11:35\u201357.","journal-title":"Crit Rev Neurobiol"},{"key":"96_CR90","first-page":"287","volume":"51","author":"RD Cone","year":"1996","unstructured":"Cone RD, Lu D, Koppula S, Vage DI, Klungland H, Boston B, et al. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res. 1996;51:287\u2013317.","journal-title":"Recent Prog Horm Res"},{"key":"96_CR91","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1126\/science.1325670","volume":"257","author":"KG Mountjoy","year":"1992","unstructured":"Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science. 1992;257:1248\u201351.","journal-title":"Science"},{"key":"96_CR92","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","volume":"84","author":"A Slominski","year":"2004","unstructured":"Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84:1155\u2013228.","journal-title":"Physiol Rev"},{"key":"96_CR93","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2796.2004.01441.x","volume":"257","author":"JE Blalock","year":"2005","unstructured":"Blalock JE. The immune system as the sixth sense. J Intern Med. 2005;257:126\u201338.","journal-title":"J Intern Med"},{"key":"96_CR94","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","volume":"132","author":"RH Oakley","year":"2013","unstructured":"Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol. 2013;132:1033\u201344.","journal-title":"J Allergy Clin Immunol"},{"key":"96_CR95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","volume":"42","author":"S Ramamoorthy","year":"2016","unstructured":"Ramamoorthy S, Cidlowski JA. Corticosteroids: mechanisms of action in health and disease. Rheum Dis Clin North Am. 2016;42:15\u201331.","journal-title":"Rheum Dis Clin North Am"},{"key":"96_CR96","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.steroids.2017.11.002","volume":"133","author":"RS Sulaiman","year":"2018","unstructured":"Sulaiman RS, Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in the eye. Steroids. 2018;133:60\u201366.","journal-title":"Steroids"},{"key":"96_CR97","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.ge.19.120185.001233","volume":"19","author":"KR Yamamoto","year":"1985","unstructured":"Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet. 1985;19:209\u201352.","journal-title":"Annu Rev Genet"},{"key":"96_CR98","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4161\/cc.21018","volume":"11","author":"RA Samarasinghe","year":"2012","unstructured":"Samarasinghe RA, Witchell SF, DeFranco DB. Cooperativity and complementarity: synergies in non-classical and classical glucocorticoid signaling. Cell Cycle. 2012;11:2819\u201327.","journal-title":"Cell Cycle"},{"key":"96_CR99","doi-asserted-by":"crossref","first-page":"213","DOI":"10.9740\/mhc.2017.09.213","volume":"7","author":"EE Tillery","year":"2017","unstructured":"Tillery EE, Clements JN, Howard Z. What\u2019s new in multiple sclerosis? Ment Health Clin. 2017;7:213\u201320.","journal-title":"Ment Health Clin"},{"key":"96_CR100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncpneuro0154","volume":"2","author":"B Hemmer","year":"2006","unstructured":"Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat Clin Pr Neurol. 2006;2:201\u201311.","journal-title":"Nat Clin Pr Neurol"},{"key":"96_CR101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/NEN.0000000000000037","volume":"73","author":"S Luchetti","year":"2014","unstructured":"Luchetti S, van Eden CG, Schuurman K, van Strien ME, Swaab DF, Huitinga I. Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions. J Neuropathol Exp Neurol. 2014;73:123\u201335.","journal-title":"J Neuropathol Exp Neurol"},{"key":"96_CR102","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","volume":"359","author":"A Compston","year":"2002","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359:1221\u201331.","journal-title":"Lancet"},{"key":"96_CR103","doi-asserted-by":"crossref","first-page":"pii: E78","DOI":"10.3390\/brainsci7070078","volume":"7","author":"N Dargahi","year":"2017","unstructured":"Dargahi N, Katsara M, Tselios T, Androutsou ME, de Courten M, Matsoukas J. Multiple sclerosis: immunopathology and treatment update. Brain Sci. 2017;7:pii: E78","journal-title":"Brain Sci"},{"key":"96_CR104","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","volume":"9","author":"A Minagar","year":"2003","unstructured":"Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler. 2003;9:540\u20139.","journal-title":"Mult Scler"},{"key":"96_CR105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:278\u201386.","journal-title":"Neurology"},{"key":"96_CR106","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","volume":"14","author":"DH Mahad","year":"2015","unstructured":"Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015;14:183\u201393.","journal-title":"Lancet Neurol"},{"key":"96_CR107","first-page":"240","volume":"37","author":"W Maidhof","year":"2012","unstructured":"Maidhof W, Hilas O. Lupus: an overview of the disease and management options. Pharm Ther. 2012;37:240\u20139.","journal-title":"Pharm Ther"},{"key":"96_CR108","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/ard.57.10.573","volume":"57","author":"M Cutolo","year":"1998","unstructured":"Cutolo M, Sulli A, Villaggio B, Seriolo B, Accardo S. Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 1998;57:573\u20137.","journal-title":"Ann Rheum Dis"},{"key":"96_CR109","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2016-000180","volume":"3","author":"R Furie","year":"2016","unstructured":"Furie R, Mitrane M, Zhao E, Das M, Li D, Becker PM. Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomised, controlled pilot study. Lupus Sci Med. 2016;3:e000180.","journal-title":"Lupus Sci Med"},{"key":"96_CR110","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1002\/art.21436","volume":"52","author":"J Li","year":"2005","unstructured":"Li J, May W, McMurray RW. Pituitary hormones and systemic lupus erythematosus. Arthritis Rheum. 2005;52:3701\u201312.","journal-title":"Arthritis Rheum"},{"key":"96_CR111","first-page":"423","volume":"112","author":"A Kuhn","year":"2015","unstructured":"Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M. The diagnosis and treatment of systemic lupus erythematosus. Dtsch Arztebl Int. 2015;112:423\u201332.","journal-title":"Dtsch Arztebl Int"},{"key":"96_CR112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.hcl.2010.09.002","volume":"27","author":"JM Kahlenberg","year":"2011","unstructured":"Kahlenberg JM, Fox DA. Advances in the medical treatment of rheumatoid arthritis. Hand Clin. 2011;27:11\u201320.","journal-title":"Hand Clin"},{"key":"96_CR113","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15.","journal-title":"Bone Res"},{"key":"96_CR114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(80)90494-5","volume":"69","author":"JM Stuart","year":"1980","unstructured":"Stuart JM, Postlethwaite AE, Townes AS, Kang AH. Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med. 1980;69:13\u20138.","journal-title":"Am J Med"},{"key":"96_CR115","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/art.1780291103","volume":"29","author":"WC Watson","year":"1986","unstructured":"Watson WC, Cremer MA, Wooley PH, Townes AS. Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum. 1986;29:1316\u201321.","journal-title":"Arthritis Rheum"},{"key":"96_CR116","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","volume":"71","author":"P Camus","year":"2004","unstructured":"Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004;71:301\u201326.","journal-title":"Respiration"},{"key":"96_CR117","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cyto.2008.11.002","volume":"45","author":"A Fromont","year":"2009","unstructured":"Fromont A, De Seze J, Fleury MC, Maillefert JF, Moreau T. Inflammatory demyelinating events following treatment with anti-tumor necrosis factor. Cytokine. 2009;45:55\u20137.","journal-title":"Cytokine"},{"key":"96_CR118","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/gut.2008.163683","volume":"58","author":"JF Kerbleski","year":"2009","unstructured":"Kerbleski JF, Gottlieb AB. Dermatological complications and safety of anti-TNF treatments. Gut. 2009;58:1033\u20139.","journal-title":"Gut"},{"key":"96_CR119","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Med (Baltim). 2007;86:242\u201351.","journal-title":"Med (Baltim)"},{"key":"96_CR120","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00296-011-2119-0","volume":"32","author":"S Nalbant","year":"2012","unstructured":"Nalbant S, Ozyurt M, Yildirim M, Kuskucu M. Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report. Rheumatol Int. 2012;32:2863\u20136.","journal-title":"Rheumatol Int"},{"key":"96_CR121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.gene.6364351","volume":"8","author":"Y Liu","year":"2007","unstructured":"Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes Immun. 2007;8:1\u201312.","journal-title":"Genes Immun"},{"key":"96_CR122","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification, management of P et al. global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377\u201385.","journal-title":"J Invest Dermatol"},{"key":"96_CR123","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","volume":"9","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and disease. Nat Rev Immunol. 2009;9:679\u201391.","journal-title":"Nat Rev Immunol"},{"key":"96_CR124","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cmet.2018.10.006","volume":"29","author":"LH Huang","year":"2019","unstructured":"Huang LH, Zinselmeyer BH, Chang CH, Saunders BT, Elvington A, Baba O, et al. Interleukin-17 drives interstitial entrapment of tissue lipoproteins in experimental psoriasis. Cell Metab. 2019;29:475\u2013487 e7.","journal-title":"Cell Metab"},{"key":"96_CR125","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/bjd.16116","volume":"178","author":"I Snast","year":"2018","unstructured":"Snast I, Reiter O, Atzmony L, Leshem YA, Hodak E, Mimouni D, et al. Psychological stress and psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2018;178:1044\u201355.","journal-title":"Br J Dermatol"},{"key":"96_CR126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201589","volume":"13","author":"D Pietrzak","year":"2018","unstructured":"Pietrzak D, Pietrzak A, Grywalska E, Kicinski P, Rolinski J, Donica H, et al. Serum concentrations of interleukin 18 and 25-hydroxyvitamin D3 correlate with depression severity in men with psoriasis. PLoS ONE. 2018;13:e0201589.","journal-title":"PLoS ONE"},{"key":"96_CR127","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2133.2008.08958.x","volume":"160","author":"A Slominski","year":"2009","unstructured":"Slominski A. On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol. 2009;160:229\u201332.","journal-title":"Br J Dermatol"},{"key":"96_CR128","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.jid.2017.02.984","volume":"137","author":"R Hannen","year":"2017","unstructured":"Hannen R, Udeh-Momoh C, Upton J, Wright M, Michael A, Gulati A, et al. Dysfunctional skin-derived glucocorticoid synthesis is a pathogenic mechanism of psoriasis. J Invest Dermatol. 2017;137:1630\u20137.","journal-title":"J Invest Dermatol"},{"key":"96_CR129","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1210\/en.2017-03230","volume":"159","author":"AT Slominski","year":"2018","unstructured":"Slominski AT, Zmijewski MA, Plonka PM, Szaflarski JP, Paus R. How UV light touches the brain and endocrine system through skin, and why. Endocrinology. 2018;159:1992\u20132007.","journal-title":"Endocrinology"},{"key":"96_CR130","doi-asserted-by":"crossref","first-page":"pii: E2297","DOI":"10.3390\/ijms18112297","volume":"18","author":"K Ronholt","year":"2017","unstructured":"Ronholt K, Iversen L. Old and new biological therapies for psoriasis. Int J Mol Sci. 2017;18:pii: E2297","journal-title":"Int J Mol Sci"},{"key":"96_CR131","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","volume":"76","author":"W Damsky","year":"2017","unstructured":"Damsky W, King BA. JAK inhibitors in dermatology: the promise of a new drug class. J Am Acad Dermatol. 2017;76:736\u201344.","journal-title":"J Am Acad Dermatol"},{"key":"96_CR132","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaci.2014.08.008","volume":"134","author":"DY Leung","year":"2014","unstructured":"Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134:769\u201379.","journal-title":"J Allergy Clin Immunol"},{"key":"96_CR133","unstructured":"Brandt EB, Sivaprasad U. Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol. 2011;2:pii: 110."},{"key":"96_CR134","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1476-5381.1967.tb01984.x","volume":"31","author":"N Jancso","year":"1967","unstructured":"Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharm Chemother. 1967;31:138\u201351.","journal-title":"Br J Pharm Chemother"},{"key":"96_CR135","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1139\/y91-096","volume":"69","author":"AI Basbaum","year":"1991","unstructured":"Basbaum AI, Levine JD. The contribution of the nervous system to inflammation and inflammatory disease. Can J Physiol Pharm. 1991;69:647\u201351.","journal-title":"Can J Physiol Pharm"},{"key":"96_CR136","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4049\/jimmunol.151.3.1587","volume":"151","author":"LJ Crofford","year":"1993","unstructured":"Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR, Remmers EF, et al. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol. 1993;151:1587\u201396.","journal-title":"J Immunol"},{"key":"96_CR137","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gut.37.4.544","volume":"37","author":"Y Kawahito","year":"1995","unstructured":"Kawahito Y, Sano H, Mukai S, Asai K, Kimura S, Yamamura Y, et al. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut. 1995;37:544\u201351.","journal-title":"Gut"},{"key":"96_CR138","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/endo.136.10.7664685","volume":"136","author":"G Mastorakos","year":"1995","unstructured":"Mastorakos G, Bouzas EA, Silver PB, Sartani G, Friedman TC, Chan CC, et al. Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. Endocrinology. 1995;136:4650\u20138.","journal-title":"Endocrinology"},{"key":"96_CR139","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jc.2003-031299","volume":"89","author":"J Seres","year":"2004","unstructured":"Seres J, Bornstein SR, Seres P, Willenberg HS, Schulte KM, Scherbaum WA, et al. Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab. 2004;89:965\u201370.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR140","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/med.21268","volume":"33","author":"V Devetzis","year":"2013","unstructured":"Devetzis V, Zarogoulidis P, Kakolyris S, Vargemezis V, Chatzaki E. The corticotropin releasing factor system in the kidney: perspectives for novel therapeutic intervention in nephrology. Med Res Rev. 2013;33:847\u201372.","journal-title":"Med Res Rev"},{"key":"96_CR141","doi-asserted-by":"crossref","first-page":"236","DOI":"10.14310\/horm.2002.1407","volume":"12","author":"KA Paschos","year":"2013","unstructured":"Paschos KA, Chouridou E, Koureta M, Lambropoulou M, Kolios G, Chatzaki E. The corticotropin releasing factor system in the liver: expression, actions and possible implications in hepatic physiology and pathology. Hormones (Athens). 2013;12:236\u201345.","journal-title":"Hormones (Athens)"},{"key":"96_CR142","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.2174\/1381612823666170228142428","volume":"23","author":"J Czimmer","year":"2017","unstructured":"Czimmer J, Tache Y. Peripheral corticotropin releasing factor signaling inhibits gastric emptying: mechanisms of action and role in stress-related gastric alterations of motor function. Curr Pharm Des. 2017;23:4042\u20137.","journal-title":"Curr Pharm Des"},{"key":"96_CR143","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/JOE-13-0422","volume":"222","author":"AT Hanna-Mitchell","year":"2014","unstructured":"Hanna-Mitchell AT, Wolf-Johnston A, Roppolo JR, Buffington TC, Birder LA. Corticotropin-releasing factor family peptide signaling in feline bladder urothelial cells. J Endocrinol. 2014;222:113\u201321.","journal-title":"J Endocrinol"},{"key":"96_CR144","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI116672","volume":"92","author":"G Mastorakos","year":"1993","unstructured":"Mastorakos G, Webster EL, Friedman TC, Chrousos GP. Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary. J Clin Invest. 1993;92:961\u20138.","journal-title":"J Clin Invest"},{"key":"96_CR145","first-page":"1046","volume":"81","author":"G Mastorakos","year":"1996","unstructured":"Mastorakos G, Scopa CD, Kao LC, Vryonidou A, Friedman TC, Kattis D, et al. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J Clin Endocrinol Metab. 1996;81:1046\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR146","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bcp.2016.07.003","volume":"116","author":"M Bohm","year":"2016","unstructured":"Bohm M, Apel M, Lowin T, Lorenz J, Jenei-Lanzl Z, Capellino S, et al. Alpha-MSH modulates cell adhesion and inflammatory responses of synovial fibroblasts from osteoarthritis patients. Biochem Pharm. 2016;116:89\u201399.","journal-title":"Biochem Pharm"},{"key":"96_CR147","volume":"9","author":"J Lorenz","year":"2014","unstructured":"Lorenz J, Seebach E, Hackmayer G, Greth C, Bauer RJ, Kleinschmidt K, et al. Melanocortin 1 receptor-signaling deficiency results in an articular cartilage phenotype and accelerates pathogenesis of surgically induced murine osteoarthritis. PLoS ONE. 2014;9:e105858.","journal-title":"PLoS ONE"},{"key":"96_CR148","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/er.2011-1016","volume":"33","author":"M Bohm","year":"2012","unstructured":"Bohm M, Grassel S. Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research. Endocr Rev. 2012;33:623\u201351.","journal-title":"Endocr Rev"},{"key":"96_CR149","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF01923606","volume":"48","author":"A Slominski","year":"1992","unstructured":"Slominski A, Paus R, Mazurkiewicz J. Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia. 1992;48:50\u20134.","journal-title":"Experientia"},{"key":"96_CR150","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/002215540004800703","volume":"48","author":"JE Mazurkiewicz","year":"2000","unstructured":"Mazurkiewicz JE, Corliss D, Slominski A. Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin. J Histochem Cytochem. 2000;48:905\u201314.","journal-title":"J Histochem Cytochem"},{"key":"96_CR151","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/1523-1747.ep12332925","volume":"108","author":"G Ermak","year":"1997","unstructured":"Ermak G, Slominski A. Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL\/6 mouse skin. J Invest Dermatol. 1997;108:160\u20135.","journal-title":"J Invest Dermatol"},{"key":"96_CR152","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/s101650200036","volume":"12","author":"S Miyazaki","year":"2002","unstructured":"Miyazaki S, Yoshikawa T, Hashiramoto A, Yamada R, Tsubouchi Y, Kohno M, et al. ACTH expression in synovium of patients with rheumatoid arthritis and Lewis rats with adjuvant arthritis. Mod Rheumatol. 2002;12:206\u201312.","journal-title":"Mod Rheumatol"},{"key":"96_CR153","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbi.2007.08.005","volume":"22","author":"EM Smith","year":"2008","unstructured":"Smith EM. Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis. Brain Behav Immun. 2008;22:3\u201314.","journal-title":"Brain Behav Immun"},{"key":"96_CR154","doi-asserted-by":"crossref","first-page":"14420","DOI":"10.3748\/wjg.v20.i39.14420","volume":"20","author":"S Koido","year":"2014","unstructured":"Koido S, Ohkusa T, Kan S, Takakura K, Saito K, Komita H, et al. Production of corticotropin-releasing factor and urocortin from human monocyte-derived dendritic cells is stimulated by commensal bacteria in intestine. World J Gastroenterol. 2014;20:14420\u20139.","journal-title":"World J Gastroenterol"},{"key":"96_CR155","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/art.20157","volume":"50","author":"AN McEvoy","year":"2004","unstructured":"McEvoy AN, Bresnihan B, FitzGerald O, Murphy EP. Cyclooxygenase 2-derived prostaglandin E2 production by corticotropin-releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2004;50:1132\u201345.","journal-title":"Arthritis Rheum"},{"key":"96_CR156","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0008-8749(92)90018-K","volume":"143","author":"SJ Leu","year":"1992","unstructured":"Leu SJ, Singh VK. Stimulation of interleukin-6 production by corticotropin-releasing factor. Cell Immunol. 1992;143:220\u20137.","journal-title":"Cell Immunol"},{"key":"96_CR157","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(90)90025-5","volume":"120","author":"VK Singh","year":"1990","unstructured":"Singh VK, Leu SJ. Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosci Lett. 1990;120:151\u20134.","journal-title":"Neurosci Lett"},{"key":"96_CR158","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/bj2810251","volume":"281","author":"P Hagan","year":"1992","unstructured":"Hagan P, Poole S, Bristow AF. Immunosuppressive activity of corticotrophin-releasing factor. Inhibition of interleukin-1 and interleukin-6 production by human mononuclear cells. Biochem J. 1992;281:251\u20134.","journal-title":"Biochem J"},{"key":"96_CR159","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-5728(89)90058-1","volume":"23","author":"VK Singh","year":"1989","unstructured":"Singh VK. Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J Neuroimmunol. 1989;23:257\u201362.","journal-title":"J Neuroimmunol"},{"key":"96_CR160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0165-5728(91)90113-L","volume":"33","author":"SJ Leu","year":"1991","unstructured":"Leu SJ, Singh VK. Modulation of natural killer cell-mediated lysis by corticotropin-releasing neurohormone. J Neuroimmunol. 1991;33:253\u201360.","journal-title":"J Neuroimmunol"},{"key":"96_CR161","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.4049\/jimmunol.142.7.2338","volume":"142","author":"A Kavelaars","year":"1989","unstructured":"Kavelaars A, Ballieux RE, Heijnen CJ. The role of IL-1 in the corticotropin-releasing factor and arginine- vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells. J Immunol. 1989;142:2338\u201342.","journal-title":"J Immunol"},{"key":"96_CR162","doi-asserted-by":"publisher","unstructured":"Song JP, Chen X, Yang G, Geng XR. Corticotropin releasing hormone activates CD14(+) cells to induce endothelial barrier dysfunction. Cell Biol Int. 2013. https:\/\/doi.org\/10.1002\/cbin.10133.","DOI":"10.1002\/cbin.10133"},{"key":"96_CR163","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaci.2011.09.008","volume":"129","author":"SH Oh","year":"2012","unstructured":"Oh SH, Park CO, Wu WH, Kim JY, Jin S, Byamba D. Corticotropin-releasing hormone downregulates IL-10 production by adaptive forkhead box protein 3-negative regulatory T cells in patients with atopic dermatitis. J Allergy Clin Immunol. 2012;129:151\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"96_CR164","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1476-5381.2011.01631.x","volume":"166","author":"DK Grammatopoulos","year":"2012","unstructured":"Grammatopoulos DK. Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Br J Pharm. 2012;166:85\u201397.","journal-title":"Br J Pharm"},{"key":"96_CR165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.31887\/DCNS.2002.4.1\/jreul","volume":"4","author":"JM Reul","year":"2002","unstructured":"Reul JM, Holsboer F. On the role of corticotropin-releasing hormone receptors in anxiety and depression. Dialogues Clin Neurosci. 2002;4:31\u201346.","journal-title":"Dialogues Clin Neurosci"},{"key":"96_CR166","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1073\/pnas.0409583102","volume":"102","author":"AM Chen","year":"2005","unstructured":"Chen AM, Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM, et al. A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc Natl Acad Sci USA. 2005;102:2620\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"96_CR167","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/jcp.20900","volume":"210","author":"C Tsatsanis","year":"2007","unstructured":"Tsatsanis C, Androulidaki A, Dermitzaki E, Gravanis A, Margioris AN. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. J Cell Physiol. 2007;210:774\u201383.","journal-title":"J Cell Physiol"},{"key":"96_CR168","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-4165(95)00159-X","volume":"1289","author":"A Slominski","year":"1996","unstructured":"Slominski A, Ermak G, Hwang J, Mazurkiewicz J, Corliss D, Eastman A. The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta. 1996;1289:247\u201351.","journal-title":"Biochim Biophys Acta"},{"key":"96_CR169","first-page":"1020","volume":"83","author":"A Slominski","year":"1998","unstructured":"Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J. Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab. 1998;83:1020\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR170","first-page":"3582","volume":"85","author":"A Slominski","year":"2000","unstructured":"Slominski A, Szczesniewski A, Wortsman J. Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab. 2000;85:3582\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR171","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1290\/1071-2690(2000)036<0211:CRHARP>2.0.CO;2","volume":"36","author":"AT Slominski","year":"2000","unstructured":"Slominski AT, Roloff B, Zbytek B, Wei ET, Fechner K, Curry J, et al. Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. Vitr Cell Dev Biol Anim. 2000;36:211\u20136.","journal-title":"Vitr Cell Dev Biol Anim"},{"key":"96_CR172","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1290\/1071-2690(2001)037<0050:PEOCRH>2.0.CO;2","volume":"37","author":"ME Quevedo","year":"2001","unstructured":"Quevedo ME, Slominski A, Pinto W, Wei E, Wortsman J. Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. Vitr Cell Dev Biol Anim. 2001;37:50\u20134.","journal-title":"Vitr Cell Dev Biol Anim"},{"key":"96_CR173","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1523-1747.2003.22145.x","volume":"122","author":"N Ito","year":"2004","unstructured":"Ito N, Ito T, Betterman A, Paus R. The human hair bulb is a source and target of CRH. J Invest Dermatol. 2004;122:235\u20137.","journal-title":"J Invest Dermatol"},{"key":"96_CR174","first-page":"287","volume":"12","author":"B Roloff","year":"1998","unstructured":"Roloff B, Fechner K, Slominski A, Furkert J, Botchkarev VA, Bulfone-Paus S, et al. Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J. 1998;12:287\u201397.","journal-title":"FASEB J"},{"key":"96_CR175","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1749-6632.1999.tb08686.x","volume":"885","author":"AT Slominski","year":"1999","unstructured":"Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, et al. Cutaneous expression of CRH and CRH-R. Is there a \u201cskin stress response system?\u201d. Ann N Y Acad Sci. 1999;885:287\u2013311.","journal-title":"Ann N Y Acad Sci"},{"key":"96_CR176","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1096\/fj.04-1968fje","volume":"19","author":"N Ito","year":"2005","unstructured":"Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J. 2005;19:1332\u20134.","journal-title":"FASEB J"},{"key":"96_CR177","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-0625.2006.00382.x","volume":"15","author":"M O\u2019Kane","year":"2006","unstructured":"O\u2019Kane M, Murphy EP, Kirby B. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. Exp Dermatol. 2006;15:143\u201353.","journal-title":"Exp Dermatol"},{"key":"96_CR178","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molmed.2014.06.002","volume":"20","author":"R Paus","year":"2014","unstructured":"Paus R, Langan EA, Vidali S, Ramot Y, Andersen B. Neuroendocrinology of the hair follicle: principles and clinical perspectives. Trends Mol Med. 2014;20:559\u201370.","journal-title":"Trends Mol Med"},{"key":"96_CR179","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11154-016-9369-9","volume":"17","author":"TC Theoharides","year":"2016","unstructured":"Theoharides TC, Stewart JM, Taracanova A, Conti P, Zouboulis CC. Neuroendocrinology of the skin. Rev Endocr Metab Disord. 2016;17:287\u201394.","journal-title":"Rev Endocr Metab Disord"},{"key":"96_CR180","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/en.2003-0851","volume":"145","author":"A Slominski","year":"2004","unstructured":"Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J. Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology. 2004;145:941\u201350.","journal-title":"Endocrinology"},{"key":"96_CR181","doi-asserted-by":"crossref","unstructured":"Zbytek B, Pfeffer LM, Slominski AT. Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes. J Endocrinol. 2004;181:R1-7.","DOI":"10.1677\/joe.0.181r001"},{"key":"96_CR182","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jcp.20530","volume":"206","author":"A Slominski","year":"2006","unstructured":"Slominski A, Zbytek B, Pisarchik A, Slominski RM, Zmijewski MA, Wortsman J. CRH functions as a growth factor\/cytokine in the skin. J Cell Physiol. 2006;206:780\u201391.","journal-title":"J Cell Physiol"},{"key":"96_CR183","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-5793(91)81274-C","volume":"291","author":"A Slominski","year":"1991","unstructured":"Slominski A. POMC gene expression in mouse and hamster melanoma cells. FEBS Lett. 1991;291:165\u20138.","journal-title":"FEBS Lett"},{"key":"96_CR184","first-page":"658","volume":"122","author":"A Slominski","year":"1993","unstructured":"Slominski A, Wortsman J, Mazurkiewicz JE, Matsuoka L, Dietrich J, Lawrence K, et al. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med. 1993;122:658\u201366.","journal-title":"J Lab Clin Med"},{"key":"96_CR185","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1172\/JCI117224","volume":"93","author":"E Schauer","year":"1994","unstructured":"Schauer E, Trautinger F, Kock A, Schwarz A, Bhardwaj R, Simon M, et al. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest. 1994;93:2258\u201362.","journal-title":"J Clin Invest"},{"key":"96_CR186","doi-asserted-by":"crossref","unstructured":"Luger TA, Paus R, Slominski A, Lipton J. The proopiomelanocortin system in cutaneous neuroimmunomodulation. An introductory overview. Annals N Y Acad Sci. 1999;885:xi-xiv.","DOI":"10.1111\/j.1749-6632.1999.tb08661.x"},{"key":"96_CR187","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mce.2013.05.007","volume":"380","author":"G Talaber","year":"2013","unstructured":"Talaber G, Jondal M, Okret S. Extra-adrenal glucocorticoid synthesis: immune regulation and aspects on local organ homeostasis. Mol Cell Endocrinol. 2013;380:89\u201398.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR188","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.02.006","volume":"137","author":"A Slominski","year":"2013","unstructured":"Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol. 2013;137:107\u201323.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"96_CR189","doi-asserted-by":"crossref","unstructured":"Taves MD, Gomez-Sanchez CE, Soma KK. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am J Physiol Endocrinol Metab. 2011;301:E11\u201324.","DOI":"10.1152\/ajpendo.00100.2011"},{"key":"96_CR190","first-page":"2746","volume":"81","author":"A Slominski","year":"1996","unstructured":"Slominski A, Ermak G, Mihm M. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab. 1996;81:2746\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR191","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1523-1747.2003.12244.x","volume":"120","author":"D Thiboutot","year":"2003","unstructured":"Thiboutot D, Jabara S, McAllister JM, Sivarajah A, Gilliland K, Cong Z, et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol. 2003;120:905\u201314.","journal-title":"J Invest Dermatol"},{"key":"96_CR192","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1074\/jbc.M110.188268","volume":"286","author":"S Vukelic","year":"2011","unstructured":"Vukelic S, Stojadinovic O, Pastar I, Rabach M, Krzyzanowska A, Lebrun E, et al. Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem. 2011;286:10265\u201375.","journal-title":"J Biol Chem"},{"key":"96_CR193","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2010.11.059","volume":"404","author":"RF Hannen","year":"2011","unstructured":"Hannen RF, Michael AE, Jaulim A, Bhogal R, Burrin JM, Philpott MP. Steroid synthesis by primary human keratinocytes; implications for skin disease. Biochem Biophys Res Commun. 2011;404:62\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"96_CR194","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/sj.jid.5700204","volume":"126","author":"A Slominski","year":"2006","unstructured":"Slominski A, Zbytek B, Szczesniewski A, Wortsman J. Cultured human dermal fibroblasts do produce cortisol. J Invest Dermatol. 2006;126:1177\u20138.","journal-title":"J Invest Dermatol"},{"key":"96_CR195","doi-asserted-by":"crossref","unstructured":"Skobowiat C, Dowdy JC, Sayre RM, Tuckey RC, Slominski A. Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation. Am J Physiol Endocrinol Metab. 2011;301:E484\u201393.","DOI":"10.1152\/ajpendo.00217.2011"},{"key":"96_CR196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2013.08.035","volume":"530","author":"C Skobowiat","year":"2013","unstructured":"Skobowiat C, Nejati R, Lu L, Williams RW, Slominski AT. Genetic variation of the cutaneous HPA axis: an analysis of UVB-induced differential responses. Gene. 2013;530:1\u20137.","journal-title":"Gene"},{"key":"96_CR197","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bjd.12096","volume":"168","author":"C Skobowiat","year":"2013","unstructured":"Skobowiat C, Sayre RM, Dowdy JC, Slominski AT. Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo. Br J Dermatol. 2013;168:595\u2013601.","journal-title":"Br J Dermatol"},{"key":"96_CR198","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/php.12642","volume":"93","author":"C Skobowiat","year":"2017","unstructured":"Skobowiat C, Postlethwaite AE, Slominski AT. Skin exposure to ultraviolet b rapidly activates systemic neuroendocrine and immunosuppressive responses. Photochem Photobio. 2017;93:1008\u201315.","journal-title":"Photochem Photobio"},{"key":"96_CR199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-19683-6_1","volume":"212","author":"AT Slominski","year":"2012","unstructured":"Slominski AT, Zmijewski MA, Skobowiat C, Zbytek B, Slominski RM, Steketee JD. Sensing the environment: regulation of local and global homeostasis by the skin\u2019s neuroendocrine system. Adv Anat Embryol Cell Biol. 2012;212:1\u2013115.","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"96_CR200","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jcp.25400","volume":"232","author":"JM Wierzbicka","year":"2017","unstructured":"Wierzbicka JM, Zmijewski MA, Antoniewicz J, Sobjanek M, Slominski AT. Differentiation of keratinocytes modulates skin HPA analog. J Cell Physiol. 2017;232:154\u201366.","journal-title":"J Cell Physiol"},{"key":"96_CR201","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0673-z","volume":"9","author":"J Bigas","year":"2018","unstructured":"Bigas J, Sevilla LM, Carceller E, Boix J, Perez P. Epidermal glucocorticoid and mineralocorticoid receptors act cooperatively to regulate epidermal development and counteract skin inflammation. Cell Death Dis. 2018;9:588.","journal-title":"Cell Death Dis"},{"key":"96_CR202","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jid.2017.01.024","volume":"137","author":"AT Slominski","year":"2017","unstructured":"Slominski AT, Zmijewski MA. Glucocorticoids inhibit wound healing: novel mechanism of action. J Invest Dermatol. 2017;137:1012\u20134.","journal-title":"J Invest Dermatol"},{"key":"96_CR203","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jid.2016.11.036","volume":"137","author":"I Jozic","year":"2017","unstructured":"Jozic I, Vukelic S, Stojadinovic O, Liang L, Ramirez HA, Pastar I, et al. Stress signals, mediated by membranous glucocorticoid receptor, activate PLC\/PKC\/GSK-3beta\/beta-catenin pathway to inhibit wound closure. J Invest Dermatol. 2017;137:1144\u201354.","journal-title":"J Invest Dermatol"},{"key":"96_CR204","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI31726","volume":"117","author":"KM Aberg","year":"2007","unstructured":"Aberg KM, Radek KA, Choi EH, Kim DK, Demerjian M, Hupe M, et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest. 2007;117:3339\u201349.","journal-title":"J Clin Invest"},{"key":"96_CR205","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1172\/JCI33508","volume":"117","author":"A Slominski","year":"2007","unstructured":"Slominski A. A nervous breakdown in the skin: stress and the epidermal barrier. J Clin Invest. 2007;117:3166\u20139.","journal-title":"J Clin Invest"},{"key":"96_CR206","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jid.2017.04.004","volume":"137","author":"AT Slominski","year":"2017","unstructured":"Slominski AT, Brozyna AA, Tuckey RC. Cutaneous glucocorticoidogenesis and cortisol signaling are defective in psoriasis. J Invest Dermatol. 2017;137:1609\u201311.","journal-title":"J Invest Dermatol"},{"key":"96_CR207","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1084\/jem.179.6.1835","volume":"179","author":"MS Vacchio","year":"1994","unstructured":"Vacchio MS, Papadopoulos V, Ashwell JD. Steroid production in the thymus: implications for thymocyte selection. J Exp Med. 1994;179:1835\u201346.","journal-title":"J Exp Med"},{"key":"96_CR208","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.steroids.2015.06.010","volume":"103","author":"G Talaber","year":"2015","unstructured":"Talaber G, Jondal M, Okret S. Local glucocorticoid production in the thymus. Steroids. 2015;103:58\u201363.","journal-title":"Steroids"},{"key":"96_CR209","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1210\/en.2009-0752","volume":"150","author":"B Costa","year":"2009","unstructured":"Costa B, Pini S, Gabelloni P, Da Pozzo E, Abelli M, Lari L, et al. The spontaneous Ala147Thr amino acid substitution within the translocator protein influences pregnenolone production in lymphomonocytes of healthy individuals. Endocrinology. 2009;150:5438\u201345.","journal-title":"Endocrinology"},{"key":"96_CR210","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1073\/pnas.1216671110","volume":"110","author":"Y Jia","year":"2013","unstructured":"Jia Y, Domenico J, Takeda K, Han J, Wang M, Armstrong M, et al. Steroidogenic enzyme Cyp11a1 regulates Type 2 CD8+ T cell skewing in allergic lung disease. Proc Natl Acad Sci USA. 2013;110:8152\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"96_CR211","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/cimm.2000.1715","volume":"206","author":"H Oka","year":"2000","unstructured":"Oka H, Emori Y, Hayashi Y, Nomoto K. Breakdown of Th cell immune responses and steroidogenic CYP11A1 expression in CD4+ T cells in a murine model implanted with B16 melanoma. Cell Immunol. 2000;206:7\u201315.","journal-title":"Cell Immunol"},{"key":"96_CR212","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.270.5234.283","volume":"270","author":"RI Scheinman","year":"1995","unstructured":"Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995;270:283\u20136.","journal-title":"Science"},{"key":"96_CR213","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jlb.60.5.563","volume":"60","author":"WY Almawi","year":"1996","unstructured":"Almawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol. 1996;60:563\u201372.","journal-title":"J Leukoc Biol"},{"key":"96_CR214","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","volume":"270","author":"N Auphan","year":"1995","unstructured":"Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995;270:286\u201390.","journal-title":"Science"},{"key":"96_CR215","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s001090050242","volume":"76","author":"M Gottlicher","year":"1998","unstructured":"Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med (Berl). 1998;76:480\u20139.","journal-title":"J Mol Med (Berl)"},{"key":"96_CR216","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1095\/biolreprod.105.045336","volume":"74","author":"T Rhen","year":"2006","unstructured":"Rhen T, Cidlowski JA. Estrogens and glucocorticoids have opposing effects on the amount and latent activity of complement proteins in the rat uterus. Biol Reprod. 2006;74:265\u201374.","journal-title":"Biol Reprod"},{"key":"96_CR217","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/mend.12.1.0044","volume":"12","author":"LI McKay","year":"1998","unstructured":"McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol. 1998;12:45\u201356.","journal-title":"Mol Endocrinol"},{"key":"96_CR218","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fendo.2015.00170","volume":"6","author":"S Ronchetti","year":"2015","unstructured":"Ronchetti S, Migliorati G, Riccardi C. GILZ as a mediator of the anti-inflammatory effects of glucocorticoids. Front Endocrinol (Lausanne). 2015;6:170.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"96_CR219","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1074-7613(00)80398-2","volume":"7","author":"F D\u2019Adamio","year":"1997","unstructured":"D\u2019Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR\/CD3-activated cell death. Immunity. 1997;7:803\u201312.","journal-title":"Immunity"},{"key":"96_CR220","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3389\/fimmu.2019.01823","volume":"10","author":"L Cannarile","year":"2019","unstructured":"Cannarile L, Delfino DV, Adorisio S, Riccardi C, Ayroldi E. Implicating the Role of GILZ in glucocorticoid modulation of T-cell activation. Front Immunol. 2019;10:1823.","journal-title":"Front Immunol"},{"key":"96_CR221","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fphar.2019.00308","volume":"10","author":"O Bereshchenko","year":"2019","unstructured":"Bereshchenko O, Migliorati G, Bruscoli S, Riccardi C. Glucocorticoid-induced leucine zipper: a novel anti-inflammatory molecule. Front Pharm. 2019;10:308.","journal-title":"Front Pharm"},{"key":"96_CR222","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids\u2013new mechanisms for old drugs. N. Engl J Med. 2005;353:1711\u201323.","journal-title":"N. Engl J Med"},{"key":"96_CR223","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-84-3-304","volume":"84","author":"AS Fauci","year":"1976","unstructured":"Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976;84:304\u201315.","journal-title":"Ann Intern Med"},{"key":"96_CR224","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","volume":"119","author":"DT Boumpas","year":"1993","unstructured":"Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med. 1993;119:1198\u2013208.","journal-title":"Ann Intern Med"},{"key":"96_CR225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0008-8749(80)90054-4","volume":"49","author":"AS Fauci","year":"1980","unstructured":"Fauci AS, Murakami T, Brandon DD, Loriaux DL, Lipsett MB. Mechanisms of corticosteroid action on lymphocyte subpopulations. VI. Lack of correlation between glucocorticosteroid receptors and the differential effects of glucocorticosteroids on T-cell subpopulations. Cell Immunol. 1980;49:43\u201350.","journal-title":"Cell Immunol"},{"key":"96_CR226","first-page":"479","volume":"101","author":"JD Slade","year":"1983","unstructured":"Slade JD, Hepburn B. Prednisone-induced alterations of circulating human lymphocyte subsets. J Lab Clin Med. 1983;101:479\u201387.","journal-title":"J Lab Clin Med"},{"key":"96_CR227","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0091-6749(78)90101-X","volume":"62","author":"GA Settipane","year":"1978","unstructured":"Settipane GA, Pudupakkam RK, McGowan JH. Corticosteroid effect on immunoglobulins. J Allergy Clin Immunol. 1978;62:162\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"96_CR228","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4049\/jimmunol.147.10.3490","volume":"147","author":"N Wallen","year":"1991","unstructured":"Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol. 1991;147:3490\u20135.","journal-title":"J Immunol"},{"key":"96_CR229","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.4049\/jimmunol.172.12.7254","volume":"172","author":"MV Andrade","year":"2004","unstructured":"Andrade MV, Hiragun T, Beaven MA. Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells. J Immunol. 2004;172:7254\u201362.","journal-title":"J Immunol"},{"key":"96_CR230","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1191\/0961203303lu362xx","volume":"12","author":"M Shodell","year":"2003","unstructured":"Shodell M, Shah K, Siegal FP. Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration. Lupus. 2003;12:222\u201330.","journal-title":"Lupus"},{"key":"96_CR231","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11154-016-9390-z","volume":"17","author":"G Nikolakis","year":"2016","unstructured":"Nikolakis G, Stratakis CA, Kanaki T, Slominski A, Zouboulis CC. Skin steroidogenesis in health and disease. Rev Endocr Metab Disord. 2016;17:247\u201358.","journal-title":"Rev Endocr Metab Disord"},{"key":"96_CR232","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/exd.12376","volume":"23","author":"AT Slominski","year":"2014","unstructured":"Slominski AT, Manna PR, Tuckey RC. Cutaneous glucocorticosteroidogenesis: securing local homeostasis and the skin integrity. Exp Dermatol. 2014;23:369\u201374.","journal-title":"Exp Dermatol"},{"key":"96_CR233","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/CDLI.5.1.18-23.1998","volume":"5","author":"WA Sewell","year":"1998","unstructured":"Sewell WA, Scurr LL, Orphanides H, Kinder S, Ludowyke RI. Induction of interleukin-4 and interleukin-5 expression in mast cells is inhibited by glucocorticoids. Clin Diagn Lab Immunol. 1998;5:18\u201323.","journal-title":"Clin Diagn Lab Immunol"},{"key":"96_CR234","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00109-006-0155-0","volume":"85","author":"I Tiala","year":"2007","unstructured":"Tiala I, Suomela S, Huuhtanen J, Wakkinen J, Holtta-Vuori M, Kainu K, et al. The CCHCR1 (HCR) gene is relevant for skin steroidogenesis and downregulated in cultured psoriatic keratinocytes. J Mol Med (Berl). 2007;85:589\u2013601.","journal-title":"J Mol Med (Berl)"},{"key":"96_CR235","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jid.2017.02.972","volume":"137","author":"MK Sarkar","year":"2017","unstructured":"Sarkar MK, Kaplan N, Tsoi LC, Xing X, Liang Y, Swindell WR, et al. Endogenous glucocorticoid deficiency in psoriasis promotes inflammation and abnormal differentiation. J Invest Dermatol. 2017;137:1474\u201383.","journal-title":"J Invest Dermatol"},{"key":"96_CR236","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/glia.23179","volume":"65","author":"R Boghozian","year":"2017","unstructured":"Boghozian R, McKenzie BA, Saito LB, Mehta N, Branton WG, Lu J, et al. Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation. Glia. 2017;65:1590\u2013606.","journal-title":"Glia"},{"key":"96_CR237","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1352458512458844","volume":"19","author":"BG Arnason","year":"2013","unstructured":"Arnason BG, Berkovich R, Catania A, Lisak RP, Zaidi M. Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult Scler. 2013;19:130\u20136.","journal-title":"Mult Scler"},{"key":"96_CR238","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(61)91030-3","volume":"2","author":"H Miller","year":"1961","unstructured":"Miller H, Newell DJ, Ridley A. Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.). Lancet. 1961;2:1120\u20132.","journal-title":"Lancet"},{"key":"96_CR239","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1191\/096120301675075008","volume":"10","author":"WW Chatham","year":"2001","unstructured":"Chatham WW, Kimberly RP. Treatment of lupus with corticosteroids. Lupus. 2001;10:140\u20137.","journal-title":"Lupus"},{"key":"96_CR240","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/0961203314532562","volume":"23","author":"JJ Fiechtner","year":"2014","unstructured":"Fiechtner JJ, Montroy T. Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial. Lupus. 2014;23:905\u201312.","journal-title":"Lupus"},{"key":"96_CR241","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/pgmj.32.365.145","volume":"32","author":"JN Harris-Jones","year":"1956","unstructured":"Harris-Jones JN. The role of ACTH and cortisone in the treatment of systemic lupus erythematosus. Postgrad Med J. 1956;32:145\u20139.","journal-title":"Postgrad Med J"},{"key":"96_CR242","first-page":"269","volume":"30","author":"D Vogl","year":"2003","unstructured":"Vogl D, Falk W, Dorner M, Scholmerich J, Straub RH. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones. J Rheumatol. 2003;30:269\u201375.","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"96_CR243","doi-asserted-by":"crossref","first-page":"ii6","DOI":"10.1093\/rheumatology\/kew348","volume":"55","author":"RH Straub","year":"2016","unstructured":"Straub RH, Cutolo M. Glucocorticoids and chronic inflammation. Rheumatol (Oxf). 2016;55 Suppl 2:ii6\u2013ii14.","journal-title":"Rheumatol (Oxf)"},{"key":"96_CR244","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-05439-1","volume":"7","author":"NA Yousri","year":"2017","unstructured":"Yousri NA, Bayoumy K, Elhaq WG, Mohney RP, Emadi SA, Hammoudeh M, et al. Large scale metabolic profiling identifies novel steroids linked to rheumatoid arthritis. Sci Rep. 2017;7:9137.","journal-title":"Sci Rep"},{"key":"96_CR245","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/art.10177","volume":"46","author":"RH Straub","year":"2002","unstructured":"Straub RH, Paimela L, Peltomaa R, Scholmerich J, Leirisalo-Repo M. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum. 2002;46:654\u201362.","journal-title":"Arthritis Rheum"},{"key":"96_CR246","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ard.2003.014274","volume":"63","author":"RH Straub","year":"2004","unstructured":"Straub RH, Weidler C, Demmel B, Herrmann M, Kees F, Schmidt M, et al. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2004;63:961\u20138.","journal-title":"Ann Rheum Dis"},{"key":"96_CR247","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.1780350704","volume":"35","author":"R Schlaghecke","year":"1992","unstructured":"Schlaghecke R, Kornely E, Wollenhaupt J, Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum. 1992;35:740\u20134.","journal-title":"Arthritis Rheum"},{"key":"96_CR248","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/art.1780370803","volume":"37","author":"R Schlaghecke","year":"1994","unstructured":"Schlaghecke R, Beuscher D, Kornely E, Specker C. Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance. Arthritis Rheum. 1994;37:1127\u201331.","journal-title":"Arthritis Rheum"},{"key":"96_CR249","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2011-2879","volume":"97","author":"C Edwards","year":"2012","unstructured":"Edwards C. Sixty years after Hench\u2013corticosteroids and chronic inflammatory disease. J Clin Endocrinol Metab. 2012;97:1443\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR250","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm.2110","volume":"16","author":"RC Axtell","year":"2010","unstructured":"Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, De Sarno P, et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med. 2010;16:406\u201312.","journal-title":"Nat Med"},{"key":"96_CR251","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052658","volume":"7","author":"AL Rowse","year":"2012","unstructured":"Rowse AL, Naves R, Cashman KS, McGuire DJ, Mbana T, Raman C, et al. Lithium controls central nervous system autoimmunity through modulation of IFN-gamma signaling. PLoS ONE. 2012;7:e52658.","journal-title":"PLoS ONE"},{"key":"96_CR252","volume":"11","author":"CA Mier-Aguilar","year":"2016","unstructured":"Mier-Aguilar CA, Cashman KS, Raman C, Soldevila G. CD5-CK2 signaling modulates Erk activation and thymocyte survival. PLoS ONE. 2016;11:e0168155.","journal-title":"PLoS ONE"},{"key":"96_CR253","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jcp.21992","volume":"223","author":"Z Janjetovic","year":"2010","unstructured":"Janjetovic Z, Tuckey RC, Nguyen MN, Thorpe EM Jr., Slominski AT. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J Cell Physiol. 2010;223:36\u201348.","journal-title":"J Cell Physiol"},{"key":"96_CR254","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1074\/jbc.M113.534172","volume":"289","author":"J Li","year":"2014","unstructured":"Li J, Daly E, Campioli E, Wabitsch M, Papadopoulos V. De novo synthesis of steroids and oxysterols in adipocytes. J Biol Chem. 2014;289:747\u201364.","journal-title":"J Biol Chem"},{"key":"96_CR255","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-2265.2008.03262.x","volume":"69","author":"SM MacKenzie","year":"2008","unstructured":"MacKenzie SM, Huda SS, Sattar N, Fraser R, Connell JM, Davies E. Depot-specific steroidogenic gene transcription in human adipose tissue. Clin Endocrinol (Oxf). 2008;69:848\u201354.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"96_CR256","doi-asserted-by":"crossref","first-page":"197","DOI":"10.12717\/DR.2016.20.3.197","volume":"20","author":"HR Byeon","year":"2016","unstructured":"Byeon HR, Lee SH. Expression of steroidogenesis-related genes in rat adipose tissues. Dev Reprod. 2016;20:197\u2013205.","journal-title":"Dev Reprod"},{"key":"96_CR257","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<528::AID-JCB16>3.0.CO;2-3","volume":"75","author":"JM Janssen","year":"1999","unstructured":"Janssen JM, Bland R, Hewison M, Coughtrie MW, Sharp S, Arts J, et al. Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function. J Cell Biochem. 1999;75:528\u201337.","journal-title":"J Cell Biochem"},{"key":"96_CR258","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/JME-15-0079","volume":"55","author":"M Rodriguez-Sanz","year":"2015","unstructured":"Rodriguez-Sanz M, Garcia-Giralt N, Prieto-Alhambra D, Servitja S, Balcells S, Pecorelli R, et al. CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss. J Mol Endocrinol. 2015;55:69\u201379.","journal-title":"J Mol Endocrinol"},{"key":"96_CR259","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1515\/hsz-2017-0205","volume":"398","author":"L Liu","year":"2017","unstructured":"Liu L, Pathak JL, Zhu YQ, Bureik M. Comparison of cytochrome P450 expression in four different human osteoblast models. Biol Chem. 2017;398:1327\u201334.","journal-title":"Biol Chem"},{"key":"96_CR260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-8993(83)90797-7","volume":"270","author":"C Corpechot","year":"1983","unstructured":"Corpechot C, Synguelakis M, Talha S, Axelson M, Sjovall J, Vihko R, et al. Pregnenolone and its sulfate ester in the rat brain. Brain Res. 1983;270:119\u201325.","journal-title":"Brain Res"},{"key":"96_CR261","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2826.1999.00407.x","volume":"11","author":"M Watzka","year":"1999","unstructured":"Watzka M, Bidlingmaier F, Schramm J, Klingmuller D, Stoffel-Wagner B. Sex- and age-specific differences in human brain CYP11A1 mRNA expression. J Neuroendocrinol. 1999;11:901\u20135.","journal-title":"J Neuroendocrinol"},{"key":"96_CR262","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0303-7207(02)00041-2","volume":"190","author":"L Yu","year":"2002","unstructured":"Yu L, Romero DG, Gomez-Sanchez CE, Gomez-Sanchez EP. Steroidogenic enzyme gene expression in the human brain. Mol Cell Endocrinol. 2002;190:9\u201317.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR263","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1523\/JNEUROSCI.22-24-10613.2002","volume":"22","author":"SR King","year":"2002","unstructured":"King SR, Manna PR, Ishii T, Syapin PJ, Ginsberg SD, Wilson K, et al. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J Neurosci. 2002;22:10613\u201320.","journal-title":"J Neurosci"},{"key":"96_CR264","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuroscience.2005.05.060","volume":"138","author":"E Lavaque","year":"2006","unstructured":"Lavaque E, Sierra A, Azcoitia I, Garcia-Segura LM. Steroidogenic acute regulatory protein in the brain. Neuroscience. 2006;138:741\u20137.","journal-title":"Neuroscience"},{"key":"96_CR265","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1398-9995.2011.02749.x","volume":"67","author":"N Hostettler","year":"2012","unstructured":"Hostettler N, Bianchi P, Gennari-Moser C, Kassahn D, Schoonjans K, Corazza N, et al. Local glucocorticoid production in the mouse lung is induced by immune cell stimulation. Allergy. 2012;67:227\u201334.","journal-title":"Allergy"},{"key":"96_CR266","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbadis.2010.12.010","volume":"1812","author":"PJ Fernandez-Marcos","year":"2011","unstructured":"Fernandez-Marcos PJ, Auwerx J, Schoonjans K. Emerging actions of the nuclear receptor LRH-1 in the gut. Biochim Biophys Acta. 2011;1812:947\u201355.","journal-title":"Biochim Biophys Acta"},{"key":"96_CR267","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00281-009-0159-2","volume":"31","author":"M Noti","year":"2009","unstructured":"Noti M, Sidler D, Brunner T. Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean? Semin Immunopathol. 2009;31:237\u201348.","journal-title":"Semin Immunopathol"},{"key":"96_CR268","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20031958","volume":"200","author":"I Cima","year":"2004","unstructured":"Cima I, Corazza N, Dick B, Fuhrer A, Herren S, Jakob S, et al. Intestinal epithelial cells synthesize glucocorticoids and regulate T cell activation. J Exp Med. 2004;200:1635\u201346.","journal-title":"J Exp Med"},{"key":"96_CR269","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/onc.2010.629","volume":"30","author":"D Sidler","year":"2011","unstructured":"Sidler D, Renzulli P, Schnoz C, Berger B, Schneider-Jakob S, Fluck C, et al. Colon cancer cells produce immunoregulatory glucocorticoids. Oncogene. 2011;30:2411\u20139.","journal-title":"Oncogene"},{"key":"96_CR270","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaci.2013.05.027","volume":"132","author":"M Wang","year":"2013","unstructured":"Wang M, Ramirez J, Han J, Jia Y, Domenico J, Seibold MA, et al. The steroidogenic enzyme Cyp11a1 is essential for development of peanut-induced intestinal anaphylaxis. J Allergy Clin Immunol. 2013;132:1174\u20131183.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"96_CR271","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2004786","volume":"7","author":"SC Huang","year":"2014","unstructured":"Huang SC, Lee CT, Chung BC. Tumor necrosis factor suppresses NR5A2 activity and intestinal glucocorticoid synthesis to sustain chronic colitis. Sci Signal. 2014;7:ra20.","journal-title":"Sci Signal"},{"key":"96_CR272","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1210\/jcem.86.12.8082","volume":"86","author":"SJ Tsai","year":"2001","unstructured":"Tsai SJ, Wu MH, Lin CC, Sun HS, Chen HM. Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab. 2001;86:5765\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR273","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/joe.0.1800135","volume":"180","author":"T Sugawara","year":"2004","unstructured":"Sugawara T, Nomura E, Fujimoto S. Expression of enzyme associated with steroid hormone synthesis and local production of steroid hormone in endometrial carcinoma cells. J Endocrinol. 2004;180:135\u201344.","journal-title":"J Endocrinol"},{"key":"96_CR274","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jc.2008-1180","volume":"94","author":"E Attar","year":"2009","unstructured":"Attar E, Tokunaga H, Imir G, Yilmaz MB, Redwine D, Putman M, et al. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab. 2009;94:623\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR275","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1210\/jcem.86.11.7925","volume":"86","author":"MJ Young","year":"2001","unstructured":"Young MJ, Clyne CD, Cole TJ, Funder JW. Cardiac steroidogenesis in the normal and failing heart. J Clin Endocrinol Metab. 2001;86:5121\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR276","first-page":"2519","volume":"85","author":"KM Kayes-Wandover","year":"2000","unstructured":"Kayes-Wandover KM, White PC. Steroidogenic enzyme gene expression in the human heart. J Clin Endocrinol Metab. 2000;85:2519\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR277","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/en.2002-220943","volume":"144","author":"AJ Casal","year":"2003","unstructured":"Casal AJ, Silvestre JS, Delcayre C, Capponi AM. Expression and modulation of steroidogenic acute regulatory protein messenger ribonucleic acid in rat cardiocytes and after myocardial infarction. Endocrinology. 2003;144:1861\u20138.","journal-title":"Endocrinology"},{"key":"96_CR278","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/HJH.0b013e328326cb04","volume":"27","author":"T Ohtani","year":"2009","unstructured":"Ohtani T, Mano T, Hikoso S, Sakata Y, Nishio M, Takeda Y, et al. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure. J Hypertens. 2009;27:1074\u201383.","journal-title":"J Hypertens"},{"key":"96_CR279","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/me.2013-1006","volume":"27","author":"E Anuka","year":"2013","unstructured":"Anuka E, Yivgi-Ohana N, Eimerl S, Garfinkel B, Melamed-Book N, Chepurkol E, et al. Infarct-induced steroidogenic acute regulatory protein: a survival role in cardiac fibroblasts. Mol Endocrinol. 2013;27:1502\u201317.","journal-title":"Mol Endocrinol"},{"key":"96_CR280","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jsbmb.2003.11.001","volume":"88","author":"L Dalla Valle","year":"2004","unstructured":"Dalla Valle L, Toffolo V, Vianello S, Belvedere P, Colombo L. Expression of cytochrome P450scc mRNA and protein in the rat kidney from birth to adulthood. J Steroid Biochem Mol Biol. 2004;88:79\u201389.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"96_CR281","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.mce.2010.10.020","volume":"332","author":"MA Pagotto","year":"2011","unstructured":"Pagotto MA, Roldan ML, Pagotto RM, Lugano MC, Pisani GB, Rogic G, et al. Localization and functional activity of cytochrome P450 side chain cleavage enzyme (CYP11A1) in the adult rat kidney. Mol Cell Endocrinol. 2011;332:253\u201360.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR282","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/en.2005-0077","volume":"146","author":"PR Provost","year":"2005","unstructured":"Provost PR, Tremblay Y. Genes involved in the adrenal pathway of glucocorticoid synthesis are transiently expressed in the developing lung. Endocrinology. 2005;146:2239\u201345.","journal-title":"Endocrinology"},{"key":"96_CR283","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.113.007690","volume":"130","author":"BA Maron","year":"2014","unstructured":"Maron BA, Oldham WM, Chan SY, Vargas SO, Arons E, Zhang YY, et al. Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis. Circulation. 2014;130:168\u201379.","journal-title":"Circulation"},{"key":"96_CR284","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00011-007-6133-3","volume":"56","author":"Y Ma","year":"2007","unstructured":"Ma Y, Ren S, Pandak WM, Li X, Ning Y, Lu C, et al. The effects of inflammatory cytokines on steroidogenic acute regulatory protein expression in macrophages. Inflamm Res. 2007;56:495\u2013501.","journal-title":"Inflamm Res"},{"key":"96_CR285","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/cvr\/cvq015","volume":"86","author":"JM Taylor","year":"2010","unstructured":"Taylor JM, Borthwick F, Bartholomew C, Graham A. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI. Cardiovasc Res. 2010;86:526\u201334.","journal-title":"Cardiovasc Res"},{"key":"96_CR286","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11745-009-3375-6","volume":"45","author":"Q Bai","year":"2010","unstructured":"Bai Q, Li X, Ning Y, Zhao F, Yin L. Mitochondrial cholesterol transporter, StAR, inhibits human THP-1 monocyte-derived macrophage apoptosis. Lipids. 2010;45:29\u201336.","journal-title":"Lipids"},{"key":"96_CR287","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbrc.2015.06.150","volume":"464","author":"PR Manna","year":"2015","unstructured":"Manna PR, Sennoune SR, Martinez-Zaguilan R, Slominski AT, Pruitt K. Regulation of retinoid mediated cholesterol efflux involves liver X receptor activation in mouse macrophages. Biochem Biophys Res Commun. 2015;464:312\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"96_CR288","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(96)03997-4","volume":"127","author":"Z Zhou","year":"1997","unstructured":"Zhou Z, Agarwal VR, Dixit N, White P, Speiser PW. Steroid 21-hydroxylase expression and activity in human lymphocytes. Mol Cell Endocrinol. 1997;127:11\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR289","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1012526406741","volume":"70","author":"M Iscan","year":"2001","unstructured":"Iscan M, Klaavuniemi T, Coban T, Kapucuoglu N, Pelkonen O, Raunio H. The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat. 2001;70:47\u201354.","journal-title":"Breast Cancer Res Treat"},{"key":"96_CR290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1749-6632.2009.03705.x","volume":"1155","author":"SE Bulun","year":"2009","unstructured":"Bulun SE, Lin Z, Zhao H, Lu M, Amin S, Reierstad S, et al. Regulation of aromatase expression in breast cancer tissue. Ann N Y Acad Sci. 2009;1155:121\u201331.","journal-title":"Ann N Y Acad Sci"},{"key":"96_CR291","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s10528-016-9756-7","volume":"54","author":"MB Tuzuner","year":"2016","unstructured":"Tuzuner MB, Ozturk T, Eronat AP, Seyhan F, Kisakesen HI, Calay Z, et al. Evaluation of local CYP17A1 and CYP19A1 expression levels as prognostic factors in postmenopausal invasive ductal breast cancer cases. Biochemical Genet. 2016;54:784\u2013802.","journal-title":"Biochemical Genet"},{"key":"96_CR292","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cea.12195","volume":"44","author":"YJ Jun","year":"2014","unstructured":"Jun YJ, Park SJ, Hwang JW, Kim TH, Jung KJ, Jung JY, et al. Differential expression of 11beta-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate\/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis. Clin Exp Allergy. 2014;44:197\u2013211.","journal-title":"Clin Exp Allergy"},{"key":"96_CR293","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1111\/bph.13273","volume":"172","author":"SJ Park","year":"2015","unstructured":"Park SJ, Kook JH, Kim HK, Kang SH, Lim SH, Kim HJ, et al. Macrolides increase the expression of 11beta-hydroxysteroid dehydrogenase 1 in human sinonasal epithelium, contributing to glucocorticoid activation in sinonasal mucosa. Br J Pharm. 2015;172:5083\u201395.","journal-title":"Br J Pharm"},{"key":"96_CR294","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/hmg\/ddr193","volume":"20","author":"M Baquie","year":"2011","unstructured":"Baquie M, St-Onge L, Kerr-Conte J, Cobo-Vuilleumier N, Lorenzo PI, Jimenez Moreno CM, et al. The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects {beta}-cells against stress-induced apoptosis. Hum Mol Genet. 2011;20:2823\u201333.","journal-title":"Hum Mol Genet"},{"key":"96_CR295","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MPA.0b013e318168dd8c","volume":"37","author":"A Morales","year":"2008","unstructured":"Morales A, Vilchis F, Chavez B, Morimoto S, Chan C, Robles-Diaz G, et al. Differential expression of steroidogenic factors 1 and 2, cytochrome p450scc, and steroidogenic acute regulatory protein in human pancreas. Pancreas. 2008;37:165\u20139.","journal-title":"Pancreas"},{"key":"96_CR296","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pros.23146","volume":"76","author":"M Sakai","year":"2016","unstructured":"Sakai M, Martinez-Arguelles DB, Aprikian AG, Magliocco AM, Papadopoulos V. De novo steroid biosynthesis in human prostate cell lines and biopsies. Prostate. 2016;76:575\u201387.","journal-title":"Prostate"},{"key":"96_CR297","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ajpath.2012.06.009","volume":"181","author":"NC Bennett","year":"2012","unstructured":"Bennett NC, Hooper JD, Lambie D, Lee CS, Yang T, Vesey DA, et al. Evidence for steroidogenic potential in human prostate cell lines and tissues. Am J Pathol. 2012;181:1078\u201387.","journal-title":"Am J Pathol"},{"key":"96_CR298","doi-asserted-by":"crossref","first-page":"R175","DOI":"10.1530\/ERC-10-0339","volume":"18","author":"C Cai","year":"2011","unstructured":"Cai C, Balk SP. Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy. Endocr Relat Cancer. 2011;18:R175\u201382.","journal-title":"Endocr Relat Cancer"},{"key":"96_CR299","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1158\/0008-5472.CAN-11-0532","volume":"71","author":"C Cai","year":"2011","unstructured":"Cai C, Chen S, Ng P, Bubley GJ, Nelson PS, Mostaghel EA, et al. Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cancer Res. 2011;71:6503\u201313.","journal-title":"Cancer Res"},{"key":"96_CR300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mce.2008.08.013","volume":"295","author":"PR Dillard","year":"2008","unstructured":"Dillard PR, Lin MF, Khan SA. Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol. Mol Cell Endocrinol. 2008;295:115\u201320.","journal-title":"Mol Cell Endocrinol"},{"key":"96_CR301","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/18715206113139990308","volume":"14","author":"AT Slominski","year":"2014","unstructured":"Slominski AT, Zmijewski MA, Semak I, Zbytek B, Pisarchik A, Li W, et al. Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem. 2014;14:77\u201396.","journal-title":"Anticancer Agents Med Chem"},{"key":"96_CR302","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10213","volume":"7","author":"M Schedel","year":"2016","unstructured":"Schedel M, Jia Y, Michel S, Takeda K, Domenico J, Joetham A, et al. 1,25D3 prevents CD8+Tc2 skewing and asthma development through VDR binding changes to the Cyp11a1 promoter. Nat Commun. 2016;7:10213.","journal-title":"Nat Commun"},{"key":"96_CR303","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.celrep.2014.04.011","volume":"7","author":"B Mahata","year":"2014","unstructured":"Mahata B, Zhang X, Kolodziejczyk AA, Proserpio V, Haim-Vilmovsky L, Taylor AE, et al. Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis. Cell Rep. 2014;7:1130\u201342.","journal-title":"Cell Rep"},{"key":"96_CR304","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1210\/en.2009-0195","volume":"150","author":"S Qiao","year":"2009","unstructured":"Qiao S, Okret S, Jondal M. Thymocyte-synthesized glucocorticoids play a role in thymocyte homeostasis and are down-regulated by adrenocorticotropic hormone. Endocrinology. 2009;150:4163\u20139.","journal-title":"Endocrinology"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41435-020-0096-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-020-0096-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-020-0096-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T14:21:42Z","timestamp":1722608502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-020-0096-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":304,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1038\/s41435-020-0096-6","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}